Dashboard
Manage Tickers

ATHAAthira Pharma, Inc.

Nasdaq athira.com


$ 2.16 $ 0.21 (10.66 %)    

Tuesday, 07-May-2024 15:54:40 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 2.18
$ 2.05
$ 2.18 x 100
$ 0.00 x 0
$ 2.04 - $ 2.18
$ 1.33 - $ 4.30
202,419
na
82.88M
$ 1.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-28-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

athira-pharma-announces-publication-of-preclinical-data-highlighting-fosgonimeton-treatment-in-models-of-alzheimers-disease
Athira Pharma Announces Publication of Pre...
04/11/2024 11:09:42

Key findings reported in the study publication regarding fosgonimeton in preclinical models of Alzheimer's disease include:...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/27/2024 20:31:13

athira-pharma-presents-clinical-and-preclinical-data-supporting-therapeutic-potential-of-fosgonimeton-in-alzheimers-and-parkinsons-diseases-at-adpd-2024-international-conference
Athira Pharma Presents Clinical and Precli...
03/08/2024 12:01:15

Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to res...

athira-pharma-announces-publication-in-frontiers-in-neuroscience-highlighting-therapeutic-potential-of-ath-1105-in-amyotrophic-lateral-sclerosis
Athira Pharma Announces Publication In Fro...
02/08/2024 21:22:59

Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to res...

athira-pharma-provides-2024-clinical-pipeline-outlook-topline-data-from-phase-23-lift-ad-trial-of-fosgonimeton-for-mild-to-moderate-alzheimers-disease-expected-in-2h-of-2024
Athira Pharma Provides 2024 Clinical Pipel...
01/08/2024 13:23:23

Plans To Initiate First-in-human Studies Of ATH-1105 For Amyotrophic Lateral Sclerosis In 1H Of 2024  

athira-pharma-has-completed-enrollment-in-the-phase-23-lift-ad-trial-of-fosgonimeton-as-a-potential-treatment-for-mild-to-moderate-alzheimers-disease-topline-data-is-on-track-for-2h-of-2024
Athira Pharma Has Completed Enrollment In ...
01/03/2024 12:08:27

15m-bet-on-this-healthcare-stock-check-out-these-4-penny-stocks-insiders-are-aggressively-buying
$1.5M Bet On This Healthcare Stock? Check ...
01/02/2024 11:40:52

The Dow Jones index closed lower by around 20 points on Friday. When insiders purchase or sell shares, it indicates their confi...

athira-pharma-announces-results-from-shape-phase-2-clinical-trial-of-fosgonimeton-for-the-treatment-of-parkinsons-disease-dementia-and-dementia-with-lewy-bodies
Athira Pharma Announces Results from SHAPE...
12/12/2023 12:02:23

 Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to re...

athira-pharma-announced-that-a-symposium-presentation-highlighting-data-from-preclinical-studies-of-ath-1105-for-amyotrophic-lateral-sclerosis-will-be-delivered-at-the-upcoming-motor-neurone-disease-association-international-symposium
Athira Pharma Announced That A Symposium P...
11/28/2023 12:16:05

athira-pharma-presents-preclinical-data-highlighting-fosgonimetons-neuroprotective-effects-against-amyloid--induced-pathological-alterations-and-neuroinflammation-in-models-of-alzheimers-disease
Athira Pharma Presents Preclinical Data Hi...
11/15/2023 13:18:16

Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to res...

athira-pharma-q3-eps-087-misses-081-estimate
Athira Pharma Q3 EPS $(0.87) Misses $(0.81...
11/09/2023 22:11:20

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.8...

athira-pharma-presents-preclinical-data-further-supporting-the-therapeutic-potential-of-ath-1105-in-amyotrophic-lateral-sclerosis
Athira Pharma Presents Preclinical Data Fu...
10/05/2023 20:32:19

New results support the neuroprotective effects of ATH-1105 in preclinical models of ALS, as indicated by consistent reduction ...

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
09/28/2023 18:32:08

  During Thursday's session, 406 companies made new 52-week lows.

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
09/11/2023 17:38:28

  Monday's session saw 175 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
09/08/2023 17:58:01

  Friday's session saw 225 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
09/07/2023 17:55:53

  On Thursday, 283 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
08/28/2023 17:54:09

  During Monday, 102 stocks hit new 52-week lows.

jmp-securities-maintains-outperform-on-athira-pharma-lowers-price-target-to-19
JMP Securities Maintains Outperform on Ath...
08/11/2023 11:43:14

JMP Securities analyst Jason Butler maintains Athira Pharma (NASDAQ:ATHA) with a Outperform and lowers the price target from...

athira-pharma-q2-eps-078-beats-079-estimate
Athira Pharma Q2 EPS $(0.78) Beats $(0.79)...
08/10/2023 21:06:00

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.79)...

athira-pharma-highlights-presentation-of-alzheimers-data
Athira Pharma Highlights Presentation Of A...
07/17/2023 11:09:52

New preclinical data demonstrate neuroprotective effects of fosgonimeton in models of amyloid-ß-mediated toxicity In preclinic...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION